J&J wins OK to promote drug for autism symptoms
548239
Johnson & Johnson won U.S. clearance  to promote its schizophrenia drug Risperdal for treating  irritability in children and adolescents with autism, health  officials said on Friday.
470175
Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved EnablexÂ® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary
642470
Drug maker Sepracor Inc. has won federal approval for a prescription insomnia medication the company is counting on to challenge larger rivals in the fast-growing $2.1 billion-a-year sleep aid market.
433134
FRIDAY, Dec. 15  (HealthDay News) -- The  U.S. Food and Drug Administration Friday gave the green light to Celebrex for use in kids older than two as a treatment for juvenile rheumatoid arthritis.
502540
Johnson & Johnson  and Pfizer Inc.  have agreed to sell the U.S. rights to five brands, including anti-diarrhea drug Kaopectate, to Chattem Inc.  for $410 million to satisfy regulatory requirements, Chattem said on Friday.
547994
NEW YORK  - D-cycloserine, a drug that has  shown to reduce symptoms in schizophrenics, appears to  significantly improve social and communication skills in  children with autism, according to the results of a small pilot  study published in the American Journal of Psychiatry.
585106
Pfizer Inc. won U.S. approval on Thursday to promote its prescription drug Lyrica for treating fibromyalgia, a chronic disease which can cause debilitating pain, sleep problems, stiffness and fatigue.
742330
OTTAWA -- The Supreme Court of Canada says it&#39;s up to the British Columbia government to decide whether or not to pay for an early childhood treatment for autism.
145170
ARIZONA-MADE HEART: An experimental artificial heart that saved a Mesa teen&#39;s life won Food and Drug Administration approval Monday, making the technology available to others throughout the country.
641877
Health-care products maker Johnson &  Johnson  won U.S. approval to sell a new HIV drug called  Intelence for patients with resistance to other therapies, U.S.  officials said on Friday.
619596
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the US Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
251744
Johnson & Johnson JNJ.N has sued   Boston Scientific Corp.BSX.N and Abbott Laboratories Inc.   ABT.N, seeking at least $5.5 billion in damages related to   J&J's failed bid for medical device maker Guidant Corp.
333819
Company says FDA has approved Cymbalta, OK&#39;d last month as antidepression, to treat diabetic pain. NEW YORK  - Eli Lilly and Co.
86246
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Cymbalta for the treatment of pain associated with nerve damage in diabetics.
567087
Scientists produce compelling evidence that autism may in some cases be linked to inflammation of the brain.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
102238
The American Psychiatric Association commends the Food and Drug Administration, and in particular its Psychopharmacologic Drugs Advisory Committee and its Pediatric Advisory Committee, for its public hearing on safe antidepressant use in pediatric patients